Sai Parenteral IPO: ₹408.79 Cr Issue Opens March 24 — Key Details, Risks & Business Breakdown
The Sai Parenteral IPO is set to hit the market next week, and there’s already quiet buzz building around it. For investors tracking fresh listings, this IPO brings a mix of steady pharma business, moderate growth numbers, and a clearly defined use of funds.Let’s break it down—simply, clearly, an...
Easy & quick